PUEBLO, CO / ACCESSWIRE / October 22, 2024 / Life Bank Chain, formerly X Genomics, today announced a rebranding that aligns the company with its mission to transform genetic data management using blockchain technology. With the involvement of Nobel Laureates Dr. Randy Schekman (Physiology or Medicine) and Dr. Eric Maskin (Economics), Life Bank Chain aims to set new standards in data security, accessibility, and personalized healthcare solutions.
The strategic rebrand reflects the company's goal to lead in both biotech and cryptocurrency sectors by creating secure, decentralized systems for genetic data. The rebranding also strengthens Life Bank Chain's ability to empower individuals, offering greater control over their genetic information while facilitating cutting-edge research and medical solutions.
Merging Blockchain with Biology for Enhanced Security and Innovation
Life Bank Chain's core mission is to combine advanced biology with blockchain to tackle challenges in data management, privacy, and accessibility. This approach will ensure the safe storage of sensitive genetic data, protecting users' privacy while still enabling the secure sharing of information for research and personalized treatments.
Dr. Randy Schekman's expertise in cell biology plays a crucial role in shaping the development of highly effective DNA and RNA solutions. His contributions influence the creation of personalized therapies that target unique genetic profiles, advancing the future of precision medicine.
"Blockchain offers a transformative way to secure genetic data, ensuring privacy without sacrificing accessibility," said Dr. Randy Schekman, advisor to Life Bank Chain. "Our work aims to bridge the gap between innovation and trust, creating solutions that will drive breakthroughs in personalized medicine."
Meanwhile, Dr. Eric Maskin provides critical insights into economic design mechanisms that ensure the token-based ecosystem remains efficient and sustainable. This combination of expertise ensures Life Bank Chain's ability to navigate the complexities of decentralized finance and personalized healthcare, leading the way for industry-wide adoption.
A Strategic Shift to Lead in Genetic Data Security
The rebranding signals Life Bank Chain's commitment to revolutionizing healthcare by introducing a new framework for data ownership. Leveraging blockchain technology, individuals will retain control over their genetic data, accessing it as needed for medical purposes while safeguarding privacy.
The project also introduces ERC-20 tokens to encourage data sharing and collaboration within the research community. This incentive structure aims to create a vibrant ecosystem of contributors while driving faster innovations in healthcare. The combination of blockchain and scientific excellence positions Life Bank Chain as a leader in both genetic data management and decentralized finance.
About Life Bank Chain
Life Bank Chain is a leader in blockchain-based solutions for genetic data management, advancing secure and personalized healthcare. Formerly known as X Genomics, the company combines cutting-edge biology with decentralized technology to create innovative, accessible, and secure data management systems. Backed by Nobel Laureates Dr. Randy Schekman and Dr. Eric Maskin, Life Bank Chain is committed to setting new standards for data privacy, accessibility, and innovation.
Media Contact
Ryan Chris - CEO
Email: contactus@lifebankchain.io
Website: https://lifebankchain.io
SOURCE: Life Bank Chain
View the original press release on accesswire.com
